References

  1. BEXXAR prescribing information, GlaxoSmithKline.


  2. Rituxan® [package insert]. South San Francisco, CA: Genentech, Inc.; 2005.


  3. Cancer.gov Dictionary. National Cancer Institute Web site. http://www.cancer.gov/dictionary. Accessed May 7, 2007.


  4. Yarbro CH. Malignant lymphomas. In: Yarbro CH, Goodman M, Frogge MH, Groenwald SL, eds. Cancer Nursing: Principles and Practice. 5th ed. Sudbury, MA: Jones and Bartlett Publishers; 2000:1329-1353.


  5. Vose JM. Bexxar: Novel radioimmunotherapy for the treatment of low-grade and transformed low-grade non-Hodgkin's lymphoma. Oncologist. 2004;9:160-172.


Click here for Important Safety Information about BEXXAR

 

Complete Prescribing Information for
BEXXAR (Tositumomab and Iodine I 131 Tositumomab)
 

[ RETURN TO TOP ]

 
 

BEXXAR HomeBEXXAR Site Mapnon-Hodgkin's lymphoma and radioimmunotherapy terms
BEXXAR non-Hodgkin's lymphoma treatment - more information

GSK Oncology